Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Clinical trial NCT05509582 · WITHDRAWN

Trial details

NCT number: NCT05509582
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Mediated Anemia Immune Mediated Thrombocytopenia Chronic GVHD

Start date: 2025-11-07
Primary completion: 2025-11-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.